R Dirk Allison Sells 4,988 Shares of Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corporation (NASDAQ:ADUS) CEO R Dirk Allison sold 4,988 shares of Addus HomeCare stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total value of $533,616.24. Following the transaction, the chief executive officer owned 185,514 shares of the company’s stock, valued at $19,846,287.72. This trade represents a 2.62% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

R Dirk Allison also recently made the following trade(s):

• On Wednesday, February 25th, R Dirk Allison sold 2,364 shares of Addus HomeCare stock. The shares were sold at an average price of $105.36, for a total value of $249,071.04.

Addus HomeCare Stock Down 3.3%

Shares of NASDAQ:ADUS traded down $3.58 during mid-day trading on Thursday, hitting $104.02. 269,378 shares of the company traded hands, compared to its average volume of 239,147. The stock has a 50-day moving average price of $109.57 and a two-hundred day moving average price of $113.08. Addus HomeCare Corporation has a 12-month low of $88.96 and a 12-month high of $124.43. The stock has a market cap of $1.92 billion, a P/E ratio of 19.97, a P/E/G ratio of 1.26 and a beta of 0.91. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.11.

Key Headlines Impacting Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Q4 earnings/earnings call emphasized continued revenue growth, margin-leverage opportunities and an M&A-driven growth strategy for 2026 — supports longer‑term earnings upside. Addus HomeCare Earnings Call Highlights Growth And Scale
• Positive Sentiment: Stephens trimmed its price target from $140 to $135 but kept an “overweight” rating — the new target implies meaningful upside from current levels, indicating analyst confidence in the company’s outlook despite the cut. Stephens price target note
• Neutral Sentiment: Addus will participate in the Raymond James Institutional Investors Conference (investor visibility event; typically neutral but can aid liquidity/coverage). Conference participation
• Neutral Sentiment: Some published short‑interest data in the feed shows zero shares (data glitch/inconsistent reporting across sources) — treat those specific zero figures with caution. MarketBeat ADUS page
• Negative Sentiment: Significant insider selling over Feb. 24–25: CEO R. Dirk Allison sold two blocks (4,988 and 2,364 shares) and multiple senior EVPs sold smaller blocks across the two days — coordinated insider sales can pressure sentiment even if individual sales are routine and pre‑planned. See CEO filing. CEO insider-sale SEC filing
• Negative Sentiment: Short interest rose earlier in February (as of Feb. 13 there were ~1.15M shares short, ~6.5% of shares outstanding and ~4.6 days‑to‑cover) — elevated short activity can amplify downward price moves. Short interest data

Wall Street Analyst Weigh In

Several analysts have recently commented on ADUS shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, January 21st. BMO Capital Markets started coverage on shares of Addus HomeCare in a research report on Thursday, November 13th. They issued a “market perform” rating and a $120.00 price objective for the company. Truist Financial set a $135.00 target price on shares of Addus HomeCare and gave the stock a “buy” rating in a research report on Wednesday, January 7th. KeyCorp reaffirmed an “overweight” rating on shares of Addus HomeCare in a report on Wednesday. Finally, Wall Street Zen raised Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research report on Monday. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $134.33.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Global Retirement Partners LLC raised its holdings in shares of Addus HomeCare by 395.7% in the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after purchasing an additional 186 shares during the period. Larson Financial Group LLC grew its holdings in Addus HomeCare by 133.3% during the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after purchasing an additional 136 shares during the period. Acumen Wealth Advisors LLC purchased a new stake in Addus HomeCare in the fourth quarter worth $29,000. Private Trust Co. NA raised its stake in shares of Addus HomeCare by 65.5% in the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock valued at $30,000 after buying an additional 112 shares during the period. Finally, Arax Advisory Partners lifted its position in shares of Addus HomeCare by 95.8% during the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after buying an additional 137 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.